Featured Research

from universities, journals, and other organizations

Investigational Drug Study May Determine If Lung Cancer Is Preventable In Cigarette Smokers

Date:
October 13, 2000
Source:
Northwestern University
Summary:
Researchers at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University are seeking participants for a study of an investigational drug that may prevent cigarette smokers from developing lung cancer.

CHICAGO --- Researchers at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University are seeking participants for a study of an investigational drug that may prevent cigarette smokers from developing lung cancer.

Cigarette smoke contains chemicals that become carcinogens when initially metabolized by the human body.

The National Cancer Institute-sponsored study will determine if the experimental drug may be able to decrease the amount of carcinogens produced from inhaled cigarette smoke.

The principal investigator for the study is Raymond C. Bergan, M.D., assistant professor of medicine at Northwestern University Medical School and a researcher at the Cancer Center.

To qualify for the investigational drug study, participants must be at least 18 years old and have no medical problems. Participants currently must smoke at least 20 cigarettes a day, have smoked to some degree for at least 10 years and have at least one failed attempt to quit smoking in the past three years. The number of cigarettes smoked per day must be fairly constant for three months prior to entering the study.


Story Source:

The above story is based on materials provided by Northwestern University. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern University. "Investigational Drug Study May Determine If Lung Cancer Is Preventable In Cigarette Smokers." ScienceDaily. ScienceDaily, 13 October 2000. <www.sciencedaily.com/releases/2000/10/001013074603.htm>.
Northwestern University. (2000, October 13). Investigational Drug Study May Determine If Lung Cancer Is Preventable In Cigarette Smokers. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/10/001013074603.htm
Northwestern University. "Investigational Drug Study May Determine If Lung Cancer Is Preventable In Cigarette Smokers." ScienceDaily. www.sciencedaily.com/releases/2000/10/001013074603.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins